You need JavaScript to view this

Spasticity complicating metrizamide myelography

Journal Article:

Abstract

Temporary but considerable increase in spasticity following myelography using metrizamide at 300 mgsI/ml concentration occurred in 4 patients. In 3 of the patients the diagnosis is uncertain, but it is likely to be some form of degenerative disease involving motor pathways in two of them; the fourth case has cervical spondylotic myelopathy. The spasticity might be related to the anticholinesterase activity of metrizamide or to competative inhibition by the deoxyglucose component of the metrizamide molecule of endogenous glucose metabolism.
Publication Date:
Sep 01, 1985
Product Type:
Journal Article
Reference Number:
FRG-84-12177; EDB-86-011135
Resource Relation:
Journal Name: Neuroradiology; (Germany, Federal Republic of); Journal Volume: 27:5
Subject:
62 RADIOLOGY AND NUCLEAR MEDICINE; METRIZAMIDE; SIDE EFFECTS; SPINAL CORD; BIOMEDICAL RADIOGRAPHY; CHOLINESTERASE; PAIN; PATIENTS; VERTEBRAE; AMIDES; BODY; CARBOXYLESTERASES; CENTRAL NERVOUS SYSTEM; CONTRAST MEDIA; DIAGNOSTIC TECHNIQUES; ENZYMES; ESTERASES; HYDROLASES; MEDICINE; NERVOUS SYSTEM; NUCLEAR MEDICINE; ORGANIC COMPOUNDS; ORGANIC NITROGEN COMPOUNDS; ORGANS; RADIOLOGY; SKELETON; SYMPTOMS; 550602* - Medicine- External Radiation in Diagnostics- (1980-)
OSTI ID:
6341902
Country of Origin:
Germany
Language:
English
Other Identifying Numbers:
Journal ID: CODEN: NRDYA
Submitting Site:
HEDB
Size:
Pages: 446-448
Announcement Date:

Journal Article:

Citation Formats

Earl, H M, Earl, C J, and Kendall, B E. Spasticity complicating metrizamide myelography. Germany: N. p., 1985. Web.
Earl, H M, Earl, C J, & Kendall, B E. Spasticity complicating metrizamide myelography. Germany.
Earl, H M, Earl, C J, and Kendall, B E. 1985. "Spasticity complicating metrizamide myelography." Germany.
@misc{etde_6341902,
title = {Spasticity complicating metrizamide myelography}
author = {Earl, H M, Earl, C J, and Kendall, B E}
abstractNote = {Temporary but considerable increase in spasticity following myelography using metrizamide at 300 mgsI/ml concentration occurred in 4 patients. In 3 of the patients the diagnosis is uncertain, but it is likely to be some form of degenerative disease involving motor pathways in two of them; the fourth case has cervical spondylotic myelopathy. The spasticity might be related to the anticholinesterase activity of metrizamide or to competative inhibition by the deoxyglucose component of the metrizamide molecule of endogenous glucose metabolism.}
journal = {Neuroradiology; (Germany, Federal Republic of)}
volume = {27:5}
journal type = {AC}
place = {Germany}
year = {1985}
month = {Sep}
}